Bnp Paribas Asset Management Holding S.A. Viking Therapeutics, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,002 shares of VKTX stock, worth $37,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,002Holding current value
$37,995% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
451Shares Held
67.9MCall Options Held
7.72MPut Options Held
3.25M-
Vanguard Group Inc Valley Forge, PA10.2MShares$385 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$229 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$143 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$123 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$119 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.91B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...